Emicizumab-kxwh Subcutaneous and Rimabotulinumtoxinb Intramuscular
Determining the interaction of Emicizumab-kxwh Subcutaneous and Rimabotulinumtoxinb Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: rimabotulinumtoxinB
Brand name: Myobloc
Synonyms: RimabotulinumtoxinB
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Rimactane
- Emicizumab-kxwh Subcutaneous-Rimantadine
- Emicizumab-kxwh Subcutaneous-Rimantadine Hydrochloride
- Emicizumab-kxwh Subcutaneous-Rimexolone
- Emicizumab-kxwh Subcutaneous-Rimexolone Ophthalmic
- Emicizumab-kxwh Subcutaneous-Rimso-50
- Rimabotulinumtoxinb Intramuscular-Emla
- Rimabotulinumtoxinb Intramuscular-Emla Topical
- Rimabotulinumtoxinb Intramuscular-Emo-Cort Scalp Solution Topical application
- Rimabotulinumtoxinb Intramuscular-Emo-Cort Topical application
- Rimabotulinumtoxinb Intramuscular-Emoquette
- Rimabotulinumtoxinb Intramuscular-Empagliflozin